N1VO34:BVMF
Novo Nordisk Bdr
23,81 R$
arrow_upward
+1,84%(+0,43) 1 Д
7. окт, 12:18:52 GMT-3 · BRL
search
Сви симболи
| Симбол | Цена | Промена | % промене |
|---|
insights_autoГенеришу се најзначајнији увиди за N1VO34...
Отвори
23,56 R$
Високо
23,86 R$
Ниско
23,37 R$
Трж. капитализација
127,52 млрд.
Прос. количина
35,94 хиљ.
Количина
7,66 хиљ.
Највиша у 52 недеље
42,43 R$
Најнижа у 52 недеље
22,90 R$
Акцијски капитал
3,39 млрд.
Бр. запослених
67 хиљ.
Отвори
23,56 R$
Високо
23,86 R$
Ниско
23,37 R$
Трж. капитализација
127,52 млрд.
Прос. количина
35,94 хиљ.
Количина
7,66 хиљ.
Највиша у 52 недеље
42,43 R$
Најнижа у 52 недеље
22,90 R$
Акцијски капитал
3,39 млрд.
Бр. запослених
67 хиљ.
Вести
Из веб-извора и од партнера за вести
Foreign Policy Journal
·
пре 2 сата
Novo Nordisk (NYSE: NVO) Stock Sits 70% Below Its Peak — Value Trap Or Generational Buying Opportunity?
Chemistry World
·
пре 6 сати
Novo goes on deal spree amid semaglutide patent expiries
Traders Union
·
пре 7 сати
Novo Nordisk stock holds $37.31 support: Technical outlook
Профил
Novo is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark's domestic economy, and it became the highest valued company in Europe. Wikipedia
Novo Nordisk Bdr – основни подаци
Главни извршни директорМазијар Мајк Дустдар
Запослени66,7 хиљ.
Основано21. 12. 1923.
СедиштеBagsværd, Велики Копенхаген, Данска
Сектор-
Веб-сајтnovonordisk.com